Literature DB >> 26055950

Flexible scope for ISO 15189 accreditation: a guidance prepared by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group Accreditation and ISO/CEN standards (WG-A/ISO).

Marc H M Thelen, Florent J L A Vanstapel, Christos Kroupis, Ines Vukasovic, Guilaime Boursier, Edward Barrett, Francisco Bernabeu Andreu, Pika Meško Brguljan, Duilio Brugnoni, Maria Lohmander, Ludek Sprongl, Tatjana Vodnik, Irina Ghita, Michel Vaubourdolle, Willem Huisman.   

Abstract

The recent revision of ISO15189 has further strengthened its position as the standard for accreditation for medical laboratories. Both for laboratories and their customers it is important that the scope of such accreditation is clear. Therefore the European co-operation for accreditation (EA) demands that the national bodies responsible for accreditation describe the scope of every laboratory accreditation in a way that leaves no room for doubt about the range of competence of the particular laboratories. According to EA recommendations scopes may be fixed, mentioning every single test that is part of the accreditation, or flexible, mentioning all combinations of medical field, examination type and materials for which the laboratory is competent. Up to now national accreditation bodies perpetuate use of fixed scopes, partly by inertia, partly out of fear that a too flexible scope may lead to over-valuation of the competence of laboratories, most countries only use fixed scopes. The EA however promotes use of flexible scopes, since this allows for more readily innovation, which contributes to quality in laboratory medicine. In this position paper, the Working Group Accreditation and ISO/CEN Standards belonging to the Quality and Regulation Committee of the EFLM recommends using an approach that has led to successful introduction of the flexible scope for ISO15189 accreditation as intended in EA-4/17 in The Netherlands. The approach is risk-based, discipline and competence-based, and focuses on defining a uniform terminology transferable across the borders of scientific disciplines, laboratories and countries.

Entities:  

Mesh:

Year:  2015        PMID: 26055950     DOI: 10.1515/cclm-2015-0257

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

1.  Gamma-Glutamyl Transferase (GGT) Is the Leading External Quality Assurance Predictor of ISO15189 Compliance for Pathology Laboratories.

Authors:  Brett A Lidbury; Gus Koerbin; Alice M Richardson; Tony Badrick
Journal:  Diagnostics (Basel)       Date:  2021-04-13

2.  Strategic establishment of an International Pharmacology Specialty Laboratory in a resource-limited setting.

Authors:  Takudzwa J Mtisi; Charles Maponga; Tsitsi G Monera-Penduka; Tinashe Mudzviti; Dexter Chagwena; Faithful Makita-Chingombe; Robin DiFranchesco; Gene D Morse
Journal:  Afr J Lab Med       Date:  2018-02-12

Review 3.  Quality Assurance in Clinical Chemistry: A Touch of Statistics and A Lot of Common Sense.

Authors:  Elvar Theodorsson
Journal:  J Med Biochem       Date:  2016-05-09       Impact factor: 3.402

4.  ISO 15189 Accreditation: Navigation Between Quality Management and Patient Safety.

Authors:  Mario Plebani; Laura Sciacovelli
Journal:  J Med Biochem       Date:  2017-07-14       Impact factor: 3.402

5.  How Does ISO 15189 Laboratory Accreditation Support the Delivery of Healthcare in Ethiopia? A Systematic Review.

Authors:  Kasaw Adane; Mekonnen Girma; Teshiwal Deress
Journal:  Ethiop J Health Sci       Date:  2019-03

Review 6.  Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part II-Operations.

Authors:  Brian A Rappold
Journal:  Ann Lab Med       Date:  2022-09-01       Impact factor: 4.941

Review 7.  Clinlabomics: leveraging clinical laboratory data by data mining strategies.

Authors:  Xiaoxia Wen; Ping Leng; Jiasi Wang; Guishu Yang; Ruiling Zu; Xiaojiong Jia; Kaijiong Zhang; Birga Anteneh Mengesha; Jian Huang; Dongsheng Wang; Huaichao Luo
Journal:  BMC Bioinformatics       Date:  2022-09-24       Impact factor: 3.307

8.  Flow Cytometric Analyses of Lymphocyte Markers in Immune Oncology: A Comprehensive Guidance for Validation Practice According to Laws and Standards.

Authors:  Claude Lambert; Gulderen Yanikkaya Demirel; Thomas Keller; Frank Preijers; Katherina Psarra; Matthias Schiemann; Mustafa Özçürümez; Ulrich Sack
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.